Phase II Trial of Hyperfractionated IMRT and Concurrent Weekly Cisplatin for Stage III and IVa Head and Neck Cancer

PURPOSE: Investigate a novel chemoradiation regimen designed to maximize locoregional control (LRC) and minimize toxicity for patients with advanced head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS: Patients received hyperfractionated intensity modulated radiation therapy (HIMRT)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maguire, Patrick D., Papagikos, Michael, Hamann, Sue, Neal, Charles, Meyerson, Martin, Hayes, Neil, Ungaro, Peter, Kotz, Kenneth, Couch, Marion, Pollock, Hoke, Tepper, Joel
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902601/
https://ncbi.nlm.nih.gov/pubmed/20378262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2009.12.046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados